Cart
sales@molnova.com
7-Ethoxycoumarin
CAS No. 31005-02-4
7-Ethoxycoumarin( —— )
Catalog No. M21250 CAS No. 31005-02-4
7-Ethoxycoumarin a typical human P450 substrate is catalyzed by both wild-type and mutant forms of CYP102A1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | 28 | In Stock |
|
| 500MG | 42 | In Stock |
|
| 1G | 61 | In Stock |
|
Biological Information
-
Product Name7-Ethoxycoumarin
-
NoteResearch use only, not for human use.
-
Brief Description7-Ethoxycoumarin a typical human P450 substrate is catalyzed by both wild-type and mutant forms of CYP102A1.
-
Description7-Ethoxycoumarin a typical human P450 substrate is catalyzed by both wild-type and mutant forms of CYP102A1.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number31005-02-4
-
Formula Weight190.19
-
Molecular FormulaC11H10O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (525.76 mM)
-
SMILESCCOc(cc1)cc(O2)c1C=CC2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tomohide Uno Ryosuke et al. Metabolism of 7-ethoxycoumarin flavanone and steroids by cytochrome P450 2C9 variants.[J]. Biopharmaceutics & Drug Disposition 2017.
molnova catalog
related products
-
5-Chloro-2-deoxyurid...
5-Chloro-2'-deoxyuridine is a thymine analog. It can be used to study the potential of hypochlorous acid damage to DNA and DNA precursors.
-
Boc-NH-C12-NH2
Boc-NH-C12-NH2 is an alkyl/ether-based PROTAC linker that can be used in the synthesis of PROTACs.
-
[Pyr3]-Amyloid β-Pro...
Amyloid β-Protein (3-42) is the precursor of Pyr peptide. Pyroglutamate-modified Aβ (pEAβ) (3-42) is the core of the amyloid template block in Alzheimer's disease. pEAβ(3-42) accelerated the aggregation of Aβ(1-42), while Aβ(1-42) significantly slowed the primary and secondary nucleation of pEAβ(3-42).
